Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'ANTIPLATELET AGENTS' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 97 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Cruz-Fernandez, JM
      Antiplatelet drugs in the treatment of acute coronary syndromes: Focus on cyclooxygenase inhibitors

      EUROPEAN HEART JOURNAL SUPPLEMENTS
    2. Chilmonczyk, Z; Siluk, D; Kaliszan, R
      Hypolipidaemic and antiplatelet agents

      EXPERT OPINION ON THERAPEUTIC PATENTS
    3. Goertler, M; Blaser, T; Krueger, S; Lutze, G; Wallesch, CW
      Acetylsalicylic acid and microembolic events detected by transcranial Doppler in symptomatic arterial stenoses

      CEREBROVASCULAR DISEASES
    4. Hankey, GJ
      Current oral antiplatelet agents to prevent atherothrombosis

      CEREBROVASCULAR DISEASES
    5. Sherman, DG
      Antithrombotic therapy in the acute phase: New approaches

      CEREBROVASCULAR DISEASES
    6. Di Minno, G; Tufano, A; Cerbone, AM
      Antithrombotic drugs for older subjects - Guidelines formulated jointly bythe Italian Societies of Haemostasis and Thrombosis (SISET) and of Gerontology and Geriatrics (SIGG)

      NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
    7. Chen, YL; Lin, KF; Shiao, MS; Chen, YT; Hong, CY; Lin, SJ
      Magnolol, a potent antioxidant from Magnolia officinalis, attenuates intimal thickening and MCP-1 expression after balloon injury of the aorta in cholesterol-fed rabbits

      BASIC RESEARCH IN CARDIOLOGY
    8. Serebruany, VL; Alford, AB; Meister, AF; Fuzaylov, SY; Gattis, WA; Gurbel, PA; O'Connor, CM
      Clinical utility of the platelet function analyzer (PFA-100) for the assessment of the platelet status in patients with congestive heart failure (EPCOT trial)

      THROMBOSIS RESEARCH
    9. Evans, A; Perez, I; Yu, G; Kalra, L
      Should stroke subtype influence anticoagulation decisions to prevent recurrence in stroke patients with atrial fibrillation?

      STROKE
    10. Lalouschek, W; Lang, W; Mullner, M
      Current strategies of secondary prevention after a cerebrovascular event -The Vienna stroke registry

      STROKE
    11. Quilliam, BJ; Lapane, KL; Eaton, CB; Mor, V
      Effect of antiplatelet and anticoagulant agents on risk of hospitalizationfor bleeding among a population of elderly nursing home stroke survivors

      STROKE
    12. Acarin, L; Gonzalez, B; Castellano, B
      Triflusal posttreatment inhibits glial nuclear factor-kappa B, downregulates the glial response, and is neuroprotective in an excitotoxic injury model in postnatal brain

      STROKE
    13. Elmi, F; Peacock, T; Schiavone, J
      Isolated profound thrombocytopenia associated with clopidogrel

      JOURNAL OF INVASIVE CARDIOLOGY
    14. Weksler, BB
      Antiplatelet agents in stroke prevention - Combination therapy: Present and future

      CEREBROVASCULAR DISEASES
    15. Chamouni, P; Lenain, P; Buchonnet, G; Merle, V; Bourgain, C; Boyer, A; Girault, C; Czernichow, P
      Difficulties in the management of an incomplete form of refractory thrombotic thrombocytopenic purpura, the usefulness of vincristine

      TRANSFUSION SCIENCE
    16. Raschke, C; Koch, HJ
      Pharmacokinetics and pharmacodynamics of oral and intravenous D,L-lysinacetylsalicylate and of oral acetylsalicylate

      PERFUSION
    17. Rock, G; Porta, C; Bobbio-Pallavicini, E
      Thrombotic thrombocytopenic purpura treatment in year 2000

      HAEMATOLOGICA
    18. Matsuo, T; Matsuo, M; Kario, K; Suzuki, S
      Characteristics of heparin-induced platelet aggregates in chronic hemodialysis with long-term heparin use

      HAEMOSTASIS
    19. Crassard, I; Niclot, P; Bousser, MG
      Aspirin and cerebral infarction.

      REVUE DE MEDECINE INTERNE
    20. Montalescot, G
      Value of antiplatelet therapy in preventing thrombotic events in generalized vascular disease

      CLINICAL CARDIOLOGY
    21. Brodison, A; Katira, R; More, RS; Chauhan, A
      Antiplatelet use in interventional cardiology

      POSTGRADUATE MEDICAL JOURNAL
    22. Wong, KS; Mok, V; Lam, WWM; Kay, R; Tang, A; Chan, YL; Woo, J
      Aspirin-associated intracerebral hemorrhage - Clinical and radiologic features

      NEUROLOGY
    23. Gratsiansky, NA
      Unstable angina - Acute coronary syndrome without ST-segment elevations. Antithrombotic treatment

      KARDIOLOGIYA
    24. Ferrer, VF; Abad, OL; Saez, DI; Vega, CP; Reina, D; Rosello, J; Iglesias, JR; Garcia, AS; Martin, JA; Ribosa, TFD
      Analysis of factors associated with the indication of anticoagulant therapy in chronic atrial fibrillation. Prospective study of 170 patients admitted to an Internal Medicine Department

      REVISTA CLINICA ESPANOLA
    25. Peterson, JG; Topol, EJ; Sapp, SK; Young, JB; Lincoff, AM; Lauer, MS
      Evaluation of the effects of aspirin combined with angiotensin-converting enzyme inhibitors in patients with coronary artery disease

      AMERICAN JOURNAL OF MEDICINE
    26. Galassi, AR; Tamburino, C; Nicosia, A; Russo, G; Grassi, R; Monaco, A; Giuffrida, G
      A randomized comparison of trapidil (triazolopyrimidine), a platelet-derived growth factor antagonist, versus aspirin in prevention of angiographic restenosis after coronary artery Palmaz-Schatz stent implantation

      CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
    27. Cimminiello, C; Toschi, V
      Atherothrombosis: the role of platelets

      EUROPEAN HEART JOURNAL SUPPLEMENTS
    28. Nenci, GG
      Unifying concept of arterial vascular disease

      EUROPEAN HEART JOURNAL SUPPLEMENTS
    29. Smith, NM; Pathansali, R; Bath, PMW
      Platelets and stroke

      VASCULAR MEDICINE
    30. Hart, RG; Benavente, O; Pearce, LA
      Increased risk of intracranial hemorrhage when aspirin is combined with warfarin: A meta-analysis and hypothesis

      CEREBROVASCULAR DISEASES
    31. Cimminiello, C; Toschi, V
      Atherothrombosis: the role of platelets

      EUROPEAN HEART JOURNAL
    32. Nenci, GG
      Unifying concept of arterial vascular disease

      EUROPEAN HEART JOURNAL
    33. Schror, K
      Antiintregrins - new antiplatelet agents for prevention and treatment of acute coronary syndrome

      WIENER KLINISCHE WOCHENSCHRIFT
    34. Wong, KS
      Risk factors for early death in acute ischemic stroke and intracerebral hemorrhage - A prospective hospital-based study in Asia

      STROKE
    35. Goertler, M; Baeumer, M; Kross, R; Blaser, T; Lutze, G; Jost, S; Wallesch, CW
      Rapid decline of cerebral microemboli of arterial origin after intravenousacetylsalicylic acid

      STROKE
    36. GUREVITZ O; GOLDFARB A; HOD H; FELDMAN M; SHENKMAN B; VARON D; ELDAR M; INBAL A
      RECOMBINANT VON-WILLEBRAND-FACTOR FRAGMENT AR545C INHIBITS PLATELET-AGGREGATION AND ENHANCES THROMBOLYSIS WITH RTPA IN A RABBIT THROMBOSIS MODEL

      Arteriosclerosis, thrombosis, and vascular biology
    37. BREDDIN HK
      ANTIPLATELET AGENTS IN CARDIOVASCULAR AND CEREBROVASCULAR DISEASES

      Clinical and applied thrombosis/hemostasis
    38. WITTIG K; ROTHE G; SCHMITZ G
      INHIBITION OF FIBRINOGEN BINDING AND SURFACE RECRUITMENT OF GPIIB IIIA AS DOSE-DEPENDENT EFFECTS OF THE RGD-MIMETIC MK-852/

      Thrombosis and haemostasis
    39. HSIEH MT; CHUEH FY; LIN MT
      MAGNOLOL DECREASES BODY-TEMPERATURE BY REDUCING 5-HYDROXYTRYPTAMINE RELEASE IN THE RAT HYPOTHALAMUS

      Clinical and experimental pharmacology and physiology
    40. Dyken, ML
      Antiplatelet agents and stroke prevention

      SEMINARS IN NEUROLOGY
    41. CHANDY T; VASUDEV SC; RAO GHR
      CHANGES IN PERICARDIAL CALCIFICATION DUE TO ANTIPLATELET AGENTS - IN-VITRO STUDIES

      Artificial organs
    42. SEBASTIAN C; SCHERLAG M; KUGELMASS A; SCHECHTER E
      PRIMARY STENT IMPLANTATION FOR ACUTE MYOCARDIAL-INFARCTION DURING PREGNANCY - USE OF ABCIXIMAB, TICLOPIDINE, AND ASPIRIN

      Catheterization and cardiovascular diagnosis
    43. OEMRAWSINGH PV; SCHALIJ MJ; UDAYACHALERM W; VANDERWALL EE; BRUSCHKE AVG
      MICRO STENT IMPLANTATION IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTIONWITHOUT ANTICOAGULATION - CLINICAL-EXPERIENCE WITH 2 DIFFERENT ANTITHROMBOTIC PROTOCOLS

      Catheterization and cardiovascular diagnosis
    44. KAGAN SA; MYERS SI
      MEDIATORS OF RESTENOSIS

      The Surgical clinics of North America
    45. HOFFMANN P; BERNAT A; SAVI P; HERBERT JM
      PREVENTION OF THROMBOSIS AND ENHANCEMENT OF THROMBOLYSIS IN RABBITS BY SR-121787, A GLYCOPROTEIN-II GLYCOPROTEIN-III ANTAGONIST

      The Journal of pharmacology and experimental therapeutics
    46. BERTRAND ME; LEGRAND V; BOLAND J; FLECK E; BONNIER J; EMMANUELSON H; VROLIX M; MISSAULT L; CHIERCHIA S; CASACCIA M; NICCOLI L; OTO A; WHITE C; WEBBPEPLOE M; VANBELLE E; MCFADDEN EP
      RANDOMIZED MULTICENTER COMPARISON OF CONVENTIONAL ANTICOAGULATION VERSUS ANTIPLATELET THERAPY IN UNPLANNED AND ELECTIVE CORONARY STENTING -THE FULL ANTICOAGULATION VERSUS ASPIRIN AND TICLOPIDINE (FANTASTIC) STUDY

      Circulation
    47. WHITE HD; FRENCH JK; ELLIS CJ
      NEW ANTIPLATELET AGENTS

      Australian and New Zealand Journal of Medicine
    48. JAMES SH; MEYERS AM
      MICROANGIOPATHIC HEMOLYTIC-ANEMIA AS A COMPLICATION OF DIABETES-MELLITUS

      The American journal of the medical sciences
    49. MATTSSON C; BJORKMAN JA; ULVINGE JC
      MELAGATRAN, AND HIRUDIN AND HEPARIN AS ADJUNCTS TO TISSUE-TYPE PLASMINOGEN-ACTIVATOR IN A CANINE MODEL OF CORONARY-ARTERY THROMBOLYSIS

      Fibrinolysis & proteolysis
    50. BUSCH M; MASUHR F; EINHAUPL KM
      MEDICAL AND SURGICAL PREVENTION OF STROKE - EXPERIENCES AROUND THE WORLD

      Cerebrovascular diseases
    51. STEINHUBL SR; MOLITERNO DJ
      GLYCOPROTEIN IIB IIIA RECEPTOR ANTAGONISTS FOR THE TREATMENT OF UNSTABLE ANGINA/

      Heart and vessels
    52. BOBBIOPALLAVICINI E; GUGLIOTTA L; CENTURIONI R; PORTA C; VIANELLI N; BILLIO A; TACCONI F; ASCARI E
      ANTIPLATELET AGENTS IN THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP) - RESULTS OF A RANDOMIZED MULTICENTER TRIAL BY THE ITALIAN-COOPERATIVE-GROUP FOR TTP

      Haematologica
    53. STAIANO N; DELLAMORTE R; DIDOMENICO C; TAFURI S; SQUILLACIOTI C; BELISARIO MA; DINATALE P
      ECHISTATIN INHIBITS PP72(SYK) AND PP125(FAK) PHOSPHORYLATION IN FIBRINOGEN-ADHERENT PLATELETS

      Biochimie
    54. MONTALESCOT G
      NEW ANTITHROMBOTIC DRUGS IN CORONARY-ARTE RY DISEASE

      La Revue de medecine interne
    55. WHEELDON N; CUMBERLAND D
      PHARMACOLOGICAL PREVENTION OF ACUTE ISCHEMIC COMPLICATIONS OF CORONARY ANGIOPLASTY

      Catheterization and cardiovascular diagnosis
    56. PONDE CK; WATSON PS; ARONEY CN; DOORIS M; GARRAHY PJ; CAMERON J; MCENIERY PT; BETT JHN
      MULTIPLE STENT IMPLANTATION IN SINGLE CORONARY-ARTERIES - ACUTE RESULTS AND 6-MONTH ANGIOGRAPHIC FOLLOW-UP

      Catheterization and cardiovascular diagnosis
    57. BARRY S; MERCIER S
      ANTIPLATELET AGENTS AND CARDIOVASCULAR PR EVENTION

      Therapie
    58. REBELLO SS; DRISCOLL EM; LUCCHESI BR
      TP-9201, A GLYCOPROTEIN IIB IIIA PLATELET RECEPTOR ANTAGONIST, PREVENTS RETHROMBOSIS AFTER SUCCESSFUL ARTERIAL THROMBOLYSIS IN THE DOG/

      Stroke
    59. MOUSA SA; MU DX; LUCCHESI BR
      PREVENTION OF CAROTID-ARTERY THROMBOSIS BY ORAL PLATELET GPIIB IIIA ANTAGONIST IN DOGS/

      Stroke
    60. DHEIN S; GOTTWALD M; GOTTWALD E; HOHLFELD T; SALAMEH A; KLAUS W
      ACETYLSALICYLIC-ACID ENHANCES ARRHYTHMOGENEITY IN A MODEL OF LOCAL ISCHEMIA OF ISOLATED RABBIT HEARTS

      European journal of pharmacology
    61. TSAI TH; CHOU CJ; TSAI WJ; CHEN CF
      MAGNOLOL INHIBITS ARACHIDONIC ACID-INDUCED RABBIT PLATELET SEROTONIN RELEASE, MEASURE BY MICROBORE HPLC WITH ELECTROCHEMICAL DETECTION

      Journal of liquid chromatography & related technologies
    62. CAIRNS JA
      THE ACUTE CORONARY ISCHEMIC SYNDROMES - THE CENTRAL ROLE OF THROMBOSIS

      Canadian journal of cardiology
    63. LIU CZ; HUR BT; HUANG TF
      MEASUREMENT OF GLYCOPROTEIN IIB IIIA BLOCKADE BY FLOW-CYTOMETRY WITH FLUORESCEIN ISOTHIOCYANATE-CONJUGATED CROTAVIRIN, A MEMBER OF DISINTEGRINS/

      Thrombosis and haemostasis
    64. SASAKI Y; ISHII I; GIDDINGS JC; YAMAMOTO J
      PROTECTIVE EFFECTS OF TICLOPIDINE AND ASPIRIN, ADMINISTERED ALONE ANDIN COMBINATION, ON THROMBUS FORMATION IN RAT CEREBRAL VESSELS

      Haemostasis
    65. BASILI S; FERRONI P; PULCINELLI FM; PETTIROSSI G; VIERI M; VIOLI F; ALESSANDRI C; CORDOVA C; GAZZANIGA PP
      POTENTIAL USEFULNESS OF ANTIPLATELET AGENTS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY-DISEASE

      Thrombosis research
    66. GOLDSTEIN LB; BONITO AJ; MATCHAR DB; DUNCAN PW; SAMSA GP
      US NATIONAL SURVEY OF PHYSICIAN PRACTICES FOR THE SECONDARY AND TERTIARY PREVENTION OF ISCHEMIC STROKE - MEDICAL THERAPY IN PATIENTS WITH CAROTID-ARTERY STENOSIS

      Stroke
    67. MORIAU M; AZERAD MA
      IMPORTANCE OF A MEDICAL-TREATMENT IN MESENTERIC VEIN-THROMBOSIS (MVT)

      Acta Gastro-Enterologica Belgica
    68. VANGIJN J
      EXTRAPOLATION OF TRIALS DATA INTO PRACTICE - WHERE IS THE LIMIT

      Cerebrovascular diseases
    69. PIANA RN; BITTL JA
      UNSTABLE ANGINA - THE ROLE OF PERCUTANEOUS CORONARY ANGIOPLASTY

      Coronary artery disease
    70. BHATTACHARYA S; JORDAN R; MACHIN S; SENIOR R; MACKIE I; SMITH CR; SCHAIBLE TF; WEISMAN HF; LAHIRI A
      BLOCKADE OF THE HUMAN PLATELET GPIIB IIIA RECEPTOR BY A MURINE MONOCLONAL-ANTIBODY FAB FRAGMENT (7E3) - POTENT DOSE-DEPENDENT INHIBITION OFPLATELET-FUNCTION/

      Cardiovascular drugs and therapy
    71. SUDO Y; KILGORE KS; LUCCHESI BR
      MONOCLONAL-ANTIBODY [7E3 F(AB')(2)] PREVENTS ARTERIAL BUT NOT VENOUS RETHROMBOSIS

      Journal of cardiovascular pharmacology
    72. HOFFKES HG; WEBER F; UPPENKAMP M; MEUSERS P; TESCHENDORF C; PHILIPP T; BRITTINGER G
      RECOVERY BY SPLENECTOMY IN PATIENTS WITH RELAPSED THROMBOTIC THROMBOCYTOPENIC PURPURA AND TREATMENT FAILURE TO PLASMA-EXCHANGE

      Seminars in thrombosis and hemostasis
    73. TSAI TH; TSAI WJ; CHOU CJ; CHEN CF
      MAGNOLOL INHIBITS COLLAGEN-INDUCED PLATELET SEROTONIN RELEASE

      Thrombosis research
    74. COCOZZA M; PICANO T; OLIVIERO U; RUSSO N; COTO V; MILANI M
      EFFECTS OF PICOTAMIDE, AN ANTITHROMBOXANE AGENT, ON CAROTID ATHEROSCLEROTIC EVOLUTION - A 2-YEAR, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY INDIABETIC-PATIENTS

      Stroke
    75. STURZENEGGER M; BEER JH; RIHS F
      MONITORING COMBINED ANTITHROMBOTIC TREATMENTS IN PATIENTS WITH PROSTHETIC HEART-VALVES USING TRANSCRANIAL DOPPLER AND COAGULATION MARKERS

      Stroke
    76. WANG JP; HO TF; CHANG LC; CHEN CC
      ANTIINFLAMMATORY EFFECT OF MAGNOLOL, ISOLATED FROM MAGNOLIA OFFICINALIS, ON A23187-INDUCED PLEURISY IN MICE

      Journal of Pharmacy and Pharmacology
    77. ZHENG XZ; SALGIA SR; THOMPSON WB; DILLINGHAM EO; BOND SE; FENG ZX; PRASAD KR; GOLLAMUDI R
      DESIGN AND SYNTHESIS OF PIPERIDINE-3-CARBOXAMIDES AS HUMAN PLATELET-AGGREGATION INHIBITORS

      Journal of medicinal chemistry
    78. GULBA DC; WAIGAND J; OSTERZIEL KJ; DIETZ R
      RISK ASSESSMENT AND SECONDARY PREVENTION FOLLOWING PTCA AND BYPASS-SURGERY

      Der Internist
    79. POPMA JJ; COLLER BS; OHMAN EM; BITTL JA; WEITZ J; KUNTZ RE; LEON MB
      ANTITHROMBOTIC THERAPY IN PATIENTS UNDERGOING CORONARY ANGIOPLASTY

      Chest
    80. KISS RG; LU HR; ROSKAMS T; JANG IK; PLOW EF; GOLD HK; COLLEN D
      TIME-COURSE OF THE EFFECTS OF A SINGLE BOLUS INJECTION OF F(AB')(2) FRAGMENTS OF THE ANTIPLATELET GPIIB IIIA ANTIBODY 7E3 ON ARTERIAL EVERSION GRAFT OCCLUSION, PLATELET-AGGREGATION, AND BLEEDING-TIME IN DOGS/

      Arteriosclerosis and thrombosis
    81. KISS RG; STASSEN JM; DECKMYN H; ROSKAMS T; GOLD HK; PLOW EF; COLLEN D
      CONTRIBUTION OF PLATELETS AND THE VESSEL WALL TO THE ANTITHROMBOTIC EFFECTS OF A SINGLE BOLUS INJECTION OF FAB FRAGMENTS OF THE ANTIPLATELET GPIIB IIIA ANTIBODY 7E3 IN A CANINE ARTERIAL EVERSION GRAFT PREPARATION/

      Arteriosclerosis and thrombosis
    82. HARBISON JW
      PREVENTION OF CEREBROVASCULAR ISCHEMIC EVENTS WITH ANTIPLATELET DRUGS- WHO BENEFITS MOST

      Cerebrovascular diseases
    83. EASTON JD
      ANTIPLATELET AGENTS FOR STROKE PREVENTION

      Cerebrovascular diseases
    84. BODE C; PETER K; KUBLER W; KATUS HA
      AGGRESSIVE THROMBOLYSIS IN ACUTE MYOCARDI AL-INFARCTION - LIMITATIONSAND POSSIBILITIES

      Zeitschrift fur Kardiologie
    85. ROTE WE; MU DX; BATES ER; NEDELMAN MA; LUCCHESI BR
      PREVENTION OF RETHROMBOSIS AFTER CORONARY THROMBOLYSIS IN A CHRONIC CANINE MODEL .2. ADJUNCTIVE THERAPY WITH R-HIRUDIN

      Journal of cardiovascular pharmacology
    86. TSAI TH; CHOU CJ; CHEN CF
      DISPOSITION OF MAGNOLOL AFTER INTRAVENOUS BOLUS AND INFUSION IN RABBITS

      Drug metabolism and disposition
    87. WITYK RJ; STERN BJ
      ISCHEMIC STROKE - TODAY AND TOMORROW

      Critical care medicine
    88. KOMIYA T; KUDO M; URABE T; MIZUNO Y
      COMPLIANCE WITH ANTIPLATELET THERAPY IN PATIENTS WITH ISCHEMIC CEREBROVASCULAR-DISEASE - ASSESSMENT BY PLATELET-AGGREGATION TESTING

      Stroke
    89. GATTI G; BARTOLI A; BERTIN D; STROLINBENEDETTI M; PERUCCA E
      PHARMACOKINETIC AND PHARMACODYNAMIC STUDIES FOLLOWING SINGLE AND MULTIPLE DOSES OF ROLAFAGREL, A NOVEL INHIBITOR OF THROMBOXANE SYNTHASE, IN NORMAL VOLUNTEERS

      European Journal of Clinical Pharmacology
    90. GATTI G; BARTOLI A; BERTIN D; STROLINBENEDETTI M; PERUCCA E
      PHARMACOKINETIC AND PHARMACODYNAMIC STUDIES FOLLOWING SINGLE AND MULTIPLE DOSES OF ROLAFAGREL, A NOVEL INHIBITOR OF THROMBOXANE SYNTHASE, IN NORMAL VOLUNTEERS

      European Journal of Clinical Pharmacology
    91. VERRY M; PANAK E; CAZENAVE JP
      ANTIPLATELET THERAPY IN THE PREVENTION OF ISCHEMIC STROKE

      Nouvelle revue francaise d'hematologie
    92. MOUSA SA; BOZARTH JM; FORSYTHE MS; JACKSON SM; LEAMY A; DIEMER MM; KAPIL RP; KNABB RM; MAYO MC; PIERCE SK; DEGRADO WF; THOOLEN MJ; REILLY TM
      ANTIPLATELET AND ANTITHROMBOTIC EFFICACY OF DMP-728, A NOVEL PLATELETGPIIB IIIA RECEPTOR ANTAGONIST/

      Circulation
    93. TENG CM; LIN CH; LIN CN; CHUNG MI; HUANG TF
      FRANGULIN-B, AN ANTAGONIST OF COLLAGEN-INDUCED PLATELET-AGGREGATION AND ADHESION, ISOLATED FROM RHAMNUS-FORMOSANA

      Thrombosis and haemostasis
    94. WANG JP; RAUNG SL; CHEN CC; KUO JS; TENG CM
      THE INHIBITORY EFFECT OF MAGNOLOL ON CUTANEOUS PERMEABILITY IN MICE IS PROBABLY MEDIATED BY A NONSELECTIVE VASCULAR HYPOREACTIVITY TO MEDIATORS

      Naunyn-Schmiedeberg's archives of pharmacology
    95. PEERLINCK K; DELEPELEIRE I; GOLDBERG M; FARRELL D; BARRETT J; HAND E; PANEBIANCO D; DECKMYN H; VERMYLEN J; ARNOUT J
      MK-383 (L-700,462), A SELECTIVE NONPEPTIDE PLATELET GLYCOPROTEIN-IIB IIIA ANTAGONIST, IS ACTIVE IN MAN/

      Circulation
    96. VANDEWERF F
      NEW THROMBOLYTIC STRATEGIES

      Australian and New Zealand Journal of Medicine
    97. MERLINI PA; CATTANEO M; SPINOLA A; ARDISSINO D; OLTRONA L; BELLI C; MANNUCCI PM
      ACTIVATION OF THE HEMOSTATIC SYSTEM DURING THROMBOLYTIC THERAPY

      The American journal of cardiology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 25/10/20 alle ore 15:40:26